BAKER BROS. ADVISORS LP: 13F holdings
CIK 12635082026Q2
| Positions | 84 |
|---|
| Reported value | $20.0bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 84 (+0 vs prior quarter) |
|---|
| Reported value | $20.0bn (+14.6%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| INCY Incyte Corporation | 30,762,330 | $3.5bn | 17.5% |
| ONC BeOne Medicines Ltd. | 8,801,567 | $2.5bn | 12.6% |
| RVMD Revolution Medicines, Inc. | 11,443,357 | $2.1bn | 10.7% |
| MDGL Madrigal Pharmaceuticals, Inc. | 2,143,131 | $1.2bn | 5.8% |
| ACAD ACADIA Pharmaceuticals Inc. | 42,912,904 | $1.1bn | 5.4% |
| KYMR Kymera Therapeutics, Inc. | 8,657,242 | $992.7m | 5.0% |
| INSM Insmed Incorporated | 8,796,111 | $937.8m | 4.7% |
| CELC Celcuity Inc. | 7,915,792 | $828.2m | 4.2% |
| KOD Kodiak Sciences Inc. | 19,919,186 | $776.1m | 3.9% |
| RYTM Rhythm Pharmaceuticals, Inc. | 5,604,483 | $622.3m | 3.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1263508")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples